Home  >  Research  >  Labs  >  Cancer Program  >  LIVER DISEASE AND CARCINOGENESIS

RESEARCH OVERVIEW

Our research group focuses on the liver progenitor/stem cell (LPSC) which we identify in patients with alcoholic liver disease (ALD), hepatitis C (HCV), genetic hemochromatosis (GH) and non-alcoholic fatty liver disease (NAFLD). An objective of our research is to utilise their presence as a diagnostic to detect early stages of pathology and their abundance as an indicator of disease severity. Since ALD, GH, HCV and NAFLD increase the likelihood of developing hepatocellular carcinoma (HCC), the LPSCs may also be useful as a prognostic for patients who will develop liver cancer.

We are well-placed to undertake these studies as we have a monoclonal antibody that detects the LPSCs in liver biopsies. Our recent studies suggest that the protein this antibody binds to is present in the blood of patients who harbour LPSCs in their liver. This raises the possibility of developing a blood test that informs clinicians of the state of the patient’s liver.

The LPSC is present in diseased liver because it has an important role in repairing the damaged organ. It is a functional stem cell that can produce cholangiocytes that make up the bile ducts; or it can produce hepatocytes that are responsible for the major functions of the liver. To better study this important liver cell, we have established LPSC lines from both the mouse and human to understand what makes them grow and how they decide between generating cholangiocytes and hepatocytes.

This work has produced a valuable resource in the form of LPSC lines that are non-cancerous and others that are tumorigenic. This provides a platform for screening and testing for anti-liver cancer drugs that are selectively effective against liver cancer cells.

 

Emeritus Professor George Yeoh

Emeritus Professor George Yeoh

Liver Disease and Carcinogenesis

Read more

LATEST NEWS

Safe Harbour Fellowships strengthen the next generation of Perkins researchers

The Harry Perkins Institute of Medical Research is proud to announce the 2025 recipients of our Safe Harbour Fellowships: Dr Rowan Sanderson and Dr Rui Hou. Established in 2022, the Safe Harbour Fellowship Fund was created to nurture and empower the next generation of researchers. The Safe Harbour Fellowship provides…

Read More

Professor Shirley Jansen AM recognised for outstanding service to vascular surgery and medical research

Western Australia-based vascular surgeon and researcher Professor Shirley Jansen has been appointed a Member of the Order of Australia (AM) in recognition of her significant service to vascular surgery as a clinician, researcher and educator. The Order of Australia recognises Australians who have demonstrated outstanding service or exceptional achievement. Appointments…

Read More

WA medical research suffers devastating blow in 2025 NHMRC funding round

Western Australia’s medical research sector has been dealt a demoralising blow in the 2025 National Health and Medical Research Council (NHMRC) Ideas Grant round, sparking urgent calls for action from the State’s research leaders. WA secured just five grants, representing a 3.8% success rate, less than half the national average.…

Read More

I'M LOOKING FOR

RESEARCH PROJECTS

TEAM MEMBERS

PUBLICATIONS